Research Paper Volume 13, Issue 22 pp 24768—24785
Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer
Figure 2. Correlation between tumor purity and immunity in CESC. (A, B) The immune and stromal scores of the low tumor purity subgroup were significantly higher than the high tumor purity subgroup. (C) GSEA results suggested that genes in the low tumor purity subgroup were mainly enriched in immune-related signaling pathways. (D) ssGSEA results showed that most immune cells were significantly increased in the low tumor purity subgroup.